Burden of Candida-related vascular graft infection: a nested-case control studyINFECTIONIF3.62024-02-080PRE
Do Anti-Biofilm Antibiotics Have a Place in the Treatment of Diabetic Foot Osteomyelitis?ANTIBIOTICS-BASELIF4.62023-02-035OAAI
Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infectionsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62022-01-147PRE
Fully oral targeted antibiotic therapy for Gram-positive cocci-related periprosthetic joint infections: a real-life before and after studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62021-08-187PRE
Low prevalence of tissue detection of cefepime and daptomycin used as empirical treatment during revision for periprosthetic joint infections: results of a prospective multicenter studyEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASESIF32021-05-203PREAI
Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective StudyANTIBIOTICS-BASELIF4.62020-12-2315OAAI
Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patientsINFECTIONIF3.62017-10-2031PREAI
Two-Step Sequential Approach for Concomitant Skin and Soft Tissue Infection and Osteomyelitis Complicating the Diabetic FootDIABETES CAREIF16.62017-10-0910OAAI
Diagnosis of primary antibody and complement deficiencies in young adults after a first invasive bacterial infectionCLINICAL MICROBIOLOGY AND INFECTIONIF8.52017-08-0125OAAI
Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infectionsEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASESIF32015-05-1926PREAI
Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking ApproachesJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-05-2862OAAI
Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligandsNUCLEIC ACIDS RESEARCHIF13.12011-12-0929OAAI
Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82011-12-0678PREAI
Cost-Effectiveness of Switch to Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Routine Bacterial IdentificationJOURNAL OF CLINICAL MICROBIOLOGYIF5.42011-12-0160OAAI